Meet our esteemed leadership team, made up of cannabinoid specialists, cannabis nurses, lawyers, entrepreneurs, and educators dedicated to cannabinoid medicine.
Executive Committee
Jordan Tishler, MDPresidentDr. Tishler is a cannabinoid specialist. He is the Founder and President of the Association of Cannabinoid Specialists. |
James WinokurVP Finance, Board of DirectorsJames is currently the CEO of CitraChem Corp, a start-up life sciences company founded on patent-pending chemical synthesis process. |
Board of Directors
Adam Abodeely, MD MBA FACS FASCRSDr. Adam Abodeely MD, MBA, FACS, FASCRS is a double Board-Certified Surgeon specializing in gastrointestinal diseases and cancer, and a cannabinoid specialist. |
Elizabeth Dost, RNElizabeth G. Dost, RN, is a senior health care executive with more than 25 years-experience in the Boston market and a cannabis nurse. |
Bryant GodfreyBryant Godfrey is a partner in the Washington, D.C. office of Foley Hoag and is Co-Chair of the firm’s FDA Practice Group. |
John MalancaThrough a family hardship in 2011, John and his wife Corinne founded United Patients Group (UPG), a trusted resource and leader in medical cannabis information and education.
|
Julia Arnsten, MD, MPHDr. Julia Arnsten is Chief of the Division of General Internal Medicine and a Professor of Medicine, Psychiatry & Behavioral Sciences, and Epidemiology & Population Health, as well as a cannabinoid specialist. |
Mark BoltonMark Bolton serves as Head of Global Public Policy for Jazz Pharmaceuticals. In that capacity, Mark oversees all international, federal, and state public policy for Jazz. |
Sandra Carrillo, MDDr. Sandra Carrillo is a cannabinoid specialist. She is President of the Colombian Medical Association of Cannabis Medicine (ASOMEDCCAM). |
Suraj Tandon, MD, FRCPCDr. Tandon has worked as a researcher and co-investigator assessing physical and mental health disparities amongst South Asian immigrants. Dr. Tandon is also a cannabinoid specialist. |
Advisory Board
Carrie ArmourCarrie Armour has over fifteen years of experience representing physicians, patients and the cannabis industry as a government affairs attorney and advocacy consultant. |
David Meiri, PhDDavid (Dedi) Meiri, PhD, is an Assistant Professor at the Faculty of Biology at the Technion Israel Institute of Technology and a member of the Technion Integrated Cancer Center (TICC). |
Deondra Asike, MDDeondra Asike, MD is double board certified in anesthesiology and pain medicine, and is a cannabinoid specialist. She is a Clinical Associate in the Department of Anesthesiology and Critical Care Medicine at Johns Hopkins since 2015. |
|